WHAT IS KAWASAKI DISEASE? WHAT ARE THE SYMPTOMS IN CHILD

Reading time is 3 mins

.
.
WHAT IS KAWASAKI DISEASE? WHAT ARE THE SYMPTOMS OF KAWASAKI DISEASE?

Kawasaki disease, which is especially common in children under the age of five and the consequences of which can be fatal, has reappeared in Europe. As the whole world in struggling with the corona virus, the relationship between Kawasaki disease and the corona virus seen in Europe has begun to be investigated. So, what is Kawasaki disease? What are the symptoms of Kawasaki? Here’s all the details.

In Europe, Kawasaki disease became curious after the detection of Kawasaki disease in some children under the age of five. The relationship between Kawasaki disease and the Decona virus, which is presumed to be caused by a virus, has begun to be studied. So, what is Kawasaki disease? What are the symptoms of Kawasaki? Here are the answers…

.
WHAT IS KAWASAKI DISEASE?

Kawasaki disease is more common in boys than in girls, and in children of Asian and Pacific Island origin. However, what is Kawasaki disease, which can affect children and young people of all racial and ethnic backgrounds? We have compiled for you in our news what you need to know about the symptoms and treatment.

Kawasaki disease, or mucocutaneous lymph node syndrome, is a disease that causes inflammation in the arteries, veins, and capillaries. It also affects your lymph nodes and causes symptoms in the nose, mouth and throat. It is the most common cause of heart disease in children. For the first time, the Japanese pediatrician Dr. The disease, described by Tomisaku Kawasaki in 1967, heals without serious problems in most cases within a few days after treatment, does not cause any permanent damage in many children. Relapses (relapses) are rare.

.
WHAT CAUSES KAWASAKI DISEASE?

– The exact cause of Kawasaki disease is still unknown.

– A mixture of genetic and environmental factors can cause Kawasaki disease.

– Some theories associate the disease with bacteria, viruses, or other environmental factors, but none has been proven.

– Some genes may increase the likelihood that your child will develop Kawasaki disease.

.
SYMPTOMS OF KAWASAKI DISEASE

Kawasaki disease occurs in stages, with signs, symptoms and signs. The condition tends to occur in late winter and spring.

The signs and symptoms are as follows:

The first stage

– High fever lasting more than three days

– Redness that occurs in the eyes without discharge

– Redness of the skin, groin and genital area, spreading from the chest to the leg

– Swelling and redness of the hands and feet

– Enlarged lymph nodes, especially in the neck

– Irritated throat, mouth and lips

– Swollen and bright red tongue (strawberry-like)

.
DURING THIS TIME, HEART PROBLEMS MAY ALSO OCCUR

Second stage

– Joint pain

– Diarrhea

– Vomit

– Bellyache

– Peeling of the skin of the hands and feet

– Enlargement of the gallbladder

– Temporary hearing loss

The third stage

At the third stage of the disease, signs and symptoms gradually disappear, unless complications develop. It can take up to eight weeks for children to regain their old energy and look normal.

Call your doctor if your child shows any of these symptoms. children younger than 1 year or older than 5 years are more likely to show incomplete symptoms. These children account for 25 percent of Kawasaki disease cases with a high risk of heart disease complications.

.
KAWASAKI DISEASE TREATMENT

A child who is thought to have Kawasaki disease should be referred to a hospital to be monitored and monitored for possible heart involvement. The purpose of first treatment is to reduce fever and inflammation and prevent heart damage. It is important to start treatment for Kawasaki disease as soon as possible.

Treatment involves the administration of high doses of aspirin and intravenous gamma globulin. In both treatments, it will reduce systemic inflammation and ensure the disappearance of acute symptoms.
.

Since it is able to prevent the occurrence of coronary abnormalities in the vast majority of patients, a high dose of intravenous globulin is an indispensable element of therapy.

.
Corticosteroids can also be used, albeit rarely.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me